Enhance your patent search with AI. Try the FREE AI-powered tool

At the Crossroads: Issues and Challenges in US Healthcare

healthorker taking the blood pressure of a man in a business attire
April 6, 2018

Overview

Part of what makes the healthcare industry massive and daunting from a business standpoint is the industry stakeholders’ being not just your typical buyer-seller-supplier combo. The several enormous healthcare industry segments include patients, providers (e.g., hospitals, labs), prescribers (e.g., physicians, clinics and pharmacy clinics), pharmacy, pharmaceutical and medical equipment manufacturers, regulators, and payers (e.g., Medicare and insurance companies). Several of these segments represent separate immense industries on their own (e.g., drug, insurance, and medical device industries). On top of this, federal and state laws and regulations impose strict requirements regarding what can be sold, how products are to be evaluated, who is going to pay for which services, who is eligible for which benefits, who can practice where, etc.

But the very same stupefying complexity and multiple maladies suffered by the industry make it a very fertile soil from which much-needed innovations can germinate. Improvements within the healthcare industry is estimated to provide revenue growth opportunities worth more than $500 billion. Achieving this will require a multi-pronged approach that targets the industry’s multiple problem areas and its many segments. In fact, the industry is already undergoing many transformations pushed by the government and various industry segments through combined approaches designed to put the industry in order.

In this report, we take a look at the issues and challenges that the US healthcare industry is facing.

Related Stories

Subscribe to our newsletter

  • Questions? Check our privacy policy.
  • This field is for validation purposes and should be left unchanged.

Patent and IP updates straight to your inbox

Sign up now to receive monthly patent news, analysis and free insight reports.

We don’t spam, we promise.

Disclaimer: 

1. Parola Analytics and Avontis are distinct entities and operate independently. Any references to Avontis or its services do not constitute a legal partnership. 

2. Parola Analytics does not provide legal services. Our services are limited to research and technical analysis. Any information provided by Parola Analytics should not be construed as legal advice.